C

Compass Therapeutics
D

CMPX

1.83000
USD
0.08
(4.57%)
مغلق
حجم التداول
50,668
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
251,788,183
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CMP
    -0.860
    (-6.45%)
    12.470 USD
    C
    CMPR
    3.990
    (4.36%)
    95.470 USD
    C
    CMPS
    -0.76000
    (-9.96%)
    6.87000 USD
الأخبار
المقالات

العنوان: Compass Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.